Idexx Laboratories (IDXX)

Nasdaq Market Closed

IDEXX Laboratories, Inc. is a global animal health diagnostics company best known for serving veterinary practices, livestock producers, and animal health professionals. The company develops, manufactures, and sells diagnostic instruments, consumables, reference laboratory services, and software that help veterinarians detect disease, monitor treatment, and manage clinical workflows.

Its companion animal business is the core of the company. IDEXX supplies in-clinic analyzers for chemistry, hematology, urinalysis, and other testing, along with single-use diagnostic kits for common canine and feline conditions. These products allow veterinarians to produce results during a patient visit, improving the speed of diagnosis and treatment decisions. IDEXX also operates a network of reference laboratories that handle more complex or high-volume testing for veterinary clinics.

Beyond diagnostics, the company provides practice management software, client communication tools, and data services used by animal hospitals to run daily operations. These products connect clinical testing with appointment scheduling, medical records, billing, and customer engagement, making IDEXX an important technology supplier as well as a laboratory and medical device company.

IDEXX also serves livestock and poultry markets with tests used to detect, monitor, and manage infectious diseases in herd and flock health programs. In addition, the company has businesses related to water testing and other diagnostic applications.

Listed under the IDXX symbol, IDEXX benefits from long-term trends such as rising pet ownership, greater spending on companion animal care, and increased use of diagnostics in veterinary medicine. A meaningful portion of its revenue comes from outside the United States, giving the company exposure to international growth in pet healthcare and food animal disease monitoring.

560.73 USD
547.04 USD
+9.91 (+1.80%)
After-hours

Last updated

Market Cap
44.23B
P/E
40.39
P/FCF
40.82
P/S
9.95
Enterprise Value
45.01B
Sector
Health Care
Industry
In Vitro and In Vivo Diagnostic Substances
Address
ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
GlobeNewswire Inc.

Veterinary Reference Laboratory Market Size to Reach USD 13.93 Billion by 2035 with 8.58% CAGR – SNS Insider

17 Feb 2026, 11:00 AM
GlobeNewswire Inc.

Veterinary Oncology Market Shares, Competition and Trends Analysis 2025-2030: Discover the Impact of Advanced Therapies and Digital Tools

03 Sept 2025, 09:41 AM
GlobeNewswire Inc.

Veterinary practice management software market to grow at a CAGR of 8% during the forecast period (2025 – 2030): Wissen Research

30 Jul 2025, 22:00 PM
GlobeNewswire Inc.

Global Swine Healthcare Market Size To Worth USD 5.96 Billion By 2033 | CAGR of 8.16% - GlobeNewswire

23 Jul 2024, 23:01 PM
GlobeNewswire Inc.

U.S. Companion Animal Diagnostics Market Insights, - GlobeNewswire

12 Jul 2024, 10:38 AM
Zacks Investment Research

IDEXX (IDXX) Business Faces Macroeconomic Woes, FX Headwinds

21 Jun 2024, 16:36 PM
Zacks Investment Research

Why Is Penumbra (PEN) Down 4.8% Since Last Earnings Report?

06 Jun 2024, 16:31 PM
Zacks Investment Research

IDEXX (IDXX) Expands Test Menu for the Catalyst Platform

06 Jun 2024, 13:55 PM
Zacks Investment Research

Why Is Idexx (IDXX) Up 5% Since Last Earnings Report?

31 May 2024, 16:31 PM
Zacks Investment Research

IDEXX (IDXX) Witnesses Rising Expenses, Currency Issues

20 May 2024, 16:18 PM
Zacks Investment Research

IDEXX (IDXX) Q1 Earnings Surpass Estimates, 2024 View Slashed

01 May 2024, 15:41 PM
Zacks Investment Research

Compared to Estimates, Idexx (IDXX) Q1 Earnings: A Look at Key Metrics

01 May 2024, 14:30 PM
Zacks Investment Research

Idexx Laboratories (IDXX) Tops Q1 Earnings Estimates

01 May 2024, 12:40 PM
Zacks Investment Research

Bruker's (BRKR) Balanced Segmental Growth, Innovation Aid

29 Apr 2024, 16:13 PM
Zacks Investment Research

Philips (PHG) Receives FDA Warning Letter Regarding CT Systems

26 Apr 2024, 18:19 PM
Zacks Investment Research

DexCom (DXCM) Q1 Earnings Beat, Strong CGM Demand Continues

26 Apr 2024, 12:29 PM
Zacks Investment Research

Revvity's (RVTY) New Launch to Boost Tuberculosis Testing

25 Apr 2024, 17:50 PM
Zacks Investment Research

CONMED (CNMD) Q1 Earnings & Revenues Surpass Estimates

25 Apr 2024, 17:44 PM
Zacks Investment Research

Veeva's (VEEV) AI Partner Program to Develop GenAI Solutions

25 Apr 2024, 17:37 PM
Zacks Investment Research

West Pharmaceutical (WST) Q1 Earnings Beat, HVP Sales Weak

25 Apr 2024, 15:31 PM
Market Cap
44.23B
Enterprise Value
45.01B
P/E
40.39
P/B
28.42
P/S
9.95
EV / EBITDA
28.95
EV / Sales
10.12
EPS
13.88
Dividend Yield
0%
P/FCF
40.82
P/CF
36.55
Free Cash Flow
1.08B
ROE
70.38%
ROA
32.35%
Debt / Equity
0.63
Current Ratio
1.12
Quick Ratio
0.82
Cash
0.15
Avg Volume
656.32K
Fundamentals Snapshot Price
560.73

Income Statement

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Revenue 1.14B 1.09B 1.11B 1.11B 998.43M
Gross profit 722.74M 658.11M 683.35M 694.73M 623.38M
Operating income 362.59M 315.61M 354.85M 373.05M 316.53M
EBITDA 400.27M 354.33M 391.47M 408.82M 350.6M
Net income 278.45M 248.19M 274.61M 293.99M 242.68M
Basic EPS 3.5 3.11 3.43 3.66 2.98
Diluted EPS 3.47 3.09 3.4 3.63 2.96

Balance Sheet

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Total assets 3.39B 3.35B 3.39B 3.33B 3.21B
Total liabilities 1.83B 1.75B 1.83B 1.87B 1.77B
Total equity 1.56B 1.61B 1.56B 1.46B 1.45B
Cash & equivalents 200.53M 180.07M 208.17M 164.59M 163.97M
Current assets 1.45B 1.41B 1.48B 1.36B 1.32B
Current liabilities 1.3B 1.15B 1.25B 1.22B 1.14B

Cash Flow

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Operating cash flow 266.25M 355.76M 402.34M 185.74M 237.96M
Investing cash flow -33.54M -28.13M -44.87M -33.63M -29.61M
Financing cash flow -211.43M -355.7M -313.31M -165.63M -330.32M
Change in cash 20.46M -28.1M 43.57M 624K -124.3M
Kind Filing Date Link
edgar index 4 — IDEXX LABORATORIES INC /DE View Filing
edgar index SD — IDEXX LABORATORIES INC /DE View Filing
form 4 Form 4 — FENNELL GEORGE View Filing
form 4 Form 4 — FENNELL GEORGE View Filing
form 4 Form 4 — FENNELL GEORGE View Filing
edgar index 144 — IDEXX LABORATORIES INC /DE View Filing
edgar index 8-K — IDEXX LABORATORIES INC /DE View Filing
eight k text 8-K — 8-K View Filing
edgar index 4 — IDEXX LABORATORIES INC /DE View Filing
edgar index 4 — IDEXX LABORATORIES INC /DE View Filing
edgar index 4 — IDEXX LABORATORIES INC /DE View Filing
edgar index 4 — IDEXX LABORATORIES INC /DE View Filing
edgar index 4 — IDEXX LABORATORIES INC /DE View Filing
edgar index 4 — IDEXX LABORATORIES INC /DE View Filing
edgar index 4 — IDEXX LABORATORIES INC /DE View Filing
edgar index 4 — IDEXX LABORATORIES INC /DE View Filing
edgar index 4 — IDEXX LABORATORIES INC /DE View Filing
form 4 Form 4 — Britt Irene Chang View Filing
form 4 Form 4 — Britt Irene Chang View Filing
form 4 Form 4 — Claflin Bruce L. View Filing
form 4 Form 4 — Claflin Bruce L. View Filing
form 4 Form 4 — ESSIG STUART View Filing
form 4 Form 4 — ESSIG STUART View Filing
form 4 Form 4 — HOOLEY JOSEPH L View Filing
form 4 Form 4 — HOOLEY JOSEPH L View Filing
form 4 Form 4 — JUNIUS DANIEL M View Filing
form 4 Form 4 — JUNIUS DANIEL M View Filing
form 4 Form 4 — Kingsley Lawrence D View Filing
form 4 Form 4 — Kingsley Lawrence D View Filing
form 4 Form 4 — Kingsley Lawrence D View Filing
form 4 Form 4 — Kingsley Lawrence D View Filing
form 4 Form 4 — Peacock Karen View Filing
form 4 Form 4 — Peacock Karen View Filing
form 4 Form 4 — SAMAD SAM View Filing
form 4 Form 4 — SAMAD SAM View Filing
form 4 Form 4 — Vandebroek Sophie V. View Filing
form 4 Form 4 — Vandebroek Sophie V. View Filing
edgar index 4 — IDEXX LABORATORIES INC /DE View Filing
edgar index 4 — IDEXX LABORATORIES INC /DE View Filing
edgar index 4 — IDEXX LABORATORIES INC /DE View Filing
edgar index 4 — IDEXX LABORATORIES INC /DE View Filing
edgar index 4 — IDEXX LABORATORIES INC /DE View Filing
edgar index 4 — IDEXX LABORATORIES INC /DE View Filing
form 4 Form 4 — HOOLEY JOSEPH L View Filing
form 4 Form 4 — HOOLEY JOSEPH L View Filing
form 4 Form 4 — JUNIUS DANIEL M View Filing
form 4 Form 4 — JUNIUS DANIEL M View Filing
form 4 Form 4 — Kingsley Lawrence D View Filing
form 4 Form 4 — Kingsley Lawrence D View Filing
form 4 Form 4 — Kingsley Lawrence D View Filing
form 4 Form 4 — Kingsley Lawrence D View Filing
form 4 Form 4 — Peacock Karen View Filing
form 4 Form 4 — Peacock Karen View Filing
form 4 Form 4 — SZOSTAK M ANNE View Filing
form 4 Form 4 — SZOSTAK M ANNE View Filing
form 4 Form 4 — SZOSTAK M ANNE View Filing
form 4 Form 4 — SZOSTAK M ANNE View Filing
form 4 Form 4 — Vandebroek Sophie V. View Filing
form 4 Form 4 — Vandebroek Sophie V. View Filing
form 4 Form 4 — Vandebroek Sophie V. View Filing
edgar index 10-Q — IDEXX LABORATORIES INC /DE View Filing
edgar index 8-K — IDEXX LABORATORIES INC /DE View Filing
eight k text 8-K — 8-K View Filing
edgar index 4 — IDEXX LABORATORIES INC /DE View Filing
form 4 Form 4 — HOOLEY JOSEPH L View Filing
edgar index SCHEDULE 13G/A — IDEXX LABORATORIES INC /DE View Filing
edgar index DEF 14A — IDEXX LABORATORIES INC /DE View Filing
edgar index DEFA14A — IDEXX LABORATORIES INC /DE View Filing
edgar index ARS — IDEXX LABORATORIES INC /DE View Filing
edgar index 8-K — IDEXX LABORATORIES INC /DE View Filing
eight k text 8-K — 8-K View Filing
edgar index PRE 14A — IDEXX LABORATORIES INC /DE View Filing
edgar index 4 — IDEXX LABORATORIES INC /DE View Filing
edgar index 4 — IDEXX LABORATORIES INC /DE View Filing
edgar index 4/A — IDEXX LABORATORIES INC /DE View Filing